China Nuokang Bio-Pharmaceutical IPO prices below range

NEW YORK Dec 9 (Reuters) - China Nuokang Bio-Pharmaceutical Inc priced shares in its initial public offering below expectations on Wednesday, according to an underwriter.

Shares in the Shenyang, China-based company sold for $9, raising about $45 million. China Nuokang had expected shares to sell for between $10 and $12 a piece. (Reporting by Clare Baldwin; editing by Carol Bishopric)